NOLA GARDNER: Open Payments
NPI 1649300328 · EAST SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$646 in 30 payments from 20 companies in 2025. Trend: 2023 $1,025 · 2024 $3,173 · 2025 $646
Food & beverage: $646
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $73 |
| Novo Nordisk Inc | 4 | $68 |
| Alexion Pharmaceuticals, Inc. | 2 | $46 |
| Abbott Laboratories | 2 | $40 |
| SANOFI-AVENTIS U.S. LLC | 1 | $38 |
| IBSA Pharma Inc. | 2 | $37 |
| Madrigal Pharmaceuticals | 1 | $32 |
| ABBVIE INC. | 2 | $29 |
| KYOWA KIRIN, INC. | 1 | $29 |
| PFIZER INC. | 2 | $28 |
Products named: Ozempic, TEPEZZA, STRENSIQ, FREESTYLE LIBRE 3, TZIELD, Tirosint, REZDIFFRA, UBRELVY.
Industry payments across NY — which companies pay providers there.
